➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Johnson and Johnson
McKesson
Baxter
Harvard Business School

Last Updated: August 1, 2021

DrugPatentWatch Database Preview

PHENOXYBENZAMINE HYDROCHLORIDE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic sources for phenoxybenzamine hydrochloride and what is the scope of patent protection?

Phenoxybenzamine hydrochloride is the generic ingredient in two branded drugs marketed by Concordia, Amneal, Hikma, and Par Pharm Inc, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for phenoxybenzamine hydrochloride. Five suppliers are listed for this compound.

Summary for PHENOXYBENZAMINE HYDROCHLORIDE
Recent Clinical Trials for PHENOXYBENZAMINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of California, Los AngelesPhase 3
Atrium Medical CenterPhase 4
Onze Lieve Vrouwe GasthuisPhase 4

See all PHENOXYBENZAMINE HYDROCHLORIDE clinical trials

Pharmacology for PHENOXYBENZAMINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for PHENOXYBENZAMINE HYDROCHLORIDE

US Patents and Regulatory Information for PHENOXYBENZAMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm Inc PHENOXYBENZAMINE HYDROCHLORIDE phenoxybenzamine hydrochloride CAPSULE;ORAL 204522-001 Jan 24, 2017 AB RX No Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Concordia DIBENZYLINE phenoxybenzamine hydrochloride CAPSULE;ORAL 008708-001 Approved Prior to Jan 1, 1982 AB RX Yes No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Hikma PHENOXYBENZAMINE HYDROCHLORIDE phenoxybenzamine hydrochloride CAPSULE;ORAL 201050-001 Jul 16, 2012 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Amneal PHENOXYBENZAMINE HYDROCHLORIDE phenoxybenzamine hydrochloride CAPSULE;ORAL 212568-001 Oct 27, 2020 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Johnson and Johnson
McKesson
Baxter
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.